Is Oncocyte Corporation (OCX) Stock worth its current valuation?
Stephens raised the price target for the Oncocyte Corporation (NASDAQ:OCX) stock from “an Overweight” to “an Equal-weight”. The rating was released on May 24, 2022, according to finviz. The research report from Stephens has initiated the stock to Overweight, with a price target set at $3.10. The stock was resumed by Piper Sandler, who disclosed […]
